Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132551) titled 'Clinical Study on the Impact of Intestinal Multidrug-Resistant Organism Colonization on Infection Risk and Prognosis in Patients with Advanced Liver Disease and Early Intervention' on Sept. 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
Advanced liver disease
Intervention:
Intervention group 1:Standard care + intestinal microecological intervention (probiotics plus prebiotics). The probiotic is a multi?strain preparation containing Bifidobacterium and Lactobacillus, taken orally once daily according to the manufa...